Literature DB >> 31467230

Fusion of the COL1A1 and FYN Genes in Epithelioid Osteoblastoma.

Ioannis Panagopoulos1, Ludmila Gorunova2, Ingvild Lobmaier3, Marius Lund-Iversen3, Kristin Andersen2, Arild Holth3, Bodil Bjerkehagen3, Sverre Heim2,4.   

Abstract

BACKGROUND/AIM: Epithelioid osteoblastoma is a rare benign tumor of the bone. Its pathogenesis is unknown and little is known regarding its genetic features.
MATERIALS AND METHODS: Cytogenetic, RNA sequencing, reverse transcription polymerase chain reaction (RT-PCR), genomic PCR, and Sanger sequencing analyses were performed on an epithelioid osteoblastoma.
RESULTS: G-banding analysis of short-term cultured tumor cells yielded a normal male karyotype in all examined metaphases. RNA sequencing detected a fusion of COL1A1 from 17q21 with FYN from 6q21. Both RT-PCR and genomic PCR together with Sanger sequencing verified the presence of a COL1A1-FYN fusion gene. In the COL1A1-FYN chimeric transcript, exon 43 of COL1A1 was fused to exon 2 of FYN. The genomic junction occurred in introns 43 and 1 of COL1A1 and FYN, respectively.
CONCLUSION: A COL1A1-FYN fusion gene was found in an epithelioid osteoblastoma resulting in deregulation of FYN. Whether COL1A1-FYN represents a consistent genetic feature of epithelioid osteoblastomas, remains to be seen. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  COL1A1; COL1A1-FYN fusion gene; Epithelioid osteoblastoma; FYN; RNA sequencing

Mesh:

Substances:

Year:  2019        PMID: 31467230      PMCID: PMC6727071          DOI: 10.21873/cgp.20141

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  35 in total

1.  Benign osteoblastoma; a category of osteoid-and bone-forming tumors other than classical osteoid osteoma, which may be mistaken for giant-cell tumor or osteogenic sarcoma.

Authors:  L LICHTENSTEIN
Journal:  Cancer       Date:  1956 Sep-Oct       Impact factor: 6.860

2.  Expression and clinical role of the dipeptidyl peptidases DPP8 and DPP9 in ovarian carcinoma.

Authors:  Marta Brunetti; Arild Holth; Ioannis Panagopoulos; Anne Cathrine Staff; Francesca Micci; Ben Davidson
Journal:  Virchows Arch       Date:  2018-11-22       Impact factor: 4.064

3.  Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes.

Authors:  Andre M Oliveira; Antonio R Perez-Atayde; Paola Dal Cin; Mark C Gebhardt; Chang-Jie Chen; James R Neff; George D Demetri; Andrew E Rosenberg; Julia A Bridge; Jonathan A Fletcher
Journal:  Oncogene       Date:  2005-05-12       Impact factor: 9.867

4.  Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB mRNA expression in dermatofibrosarcoma protuberans.

Authors:  Tomonari Takahira; Yoshinao Oda; Sadafumi Tamiya; Koichi Higaki; Hidetaka Yamamoto; Chikashi Kobayashi; Teiyu Izumi; Naomi Tateishi; Yukihide Iwamoto; Masazumi Tsuneyoshi
Journal:  Mod Pathol       Date:  2007-04-13       Impact factor: 7.842

5.  Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma.

Authors:  M P Simon; F Pedeutour; N Sirvent; J Grosgeorge; F Minoletti; J M Coindre; M J Terrier-Lacombe; N Mandahl; R D Craver; N Blin; G Sozzi; C Turc-Carel; K P O'Brien; D Kedra; I Fransson; C Guilbaud; J P Dumanski
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

Review 6.  Fyn: a novel molecular target in cancer.

Authors:  Yoshihito D Saito; Ana R Jensen; Ravi Salgia; Edwin M Posadas
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

7.  Osteoblastoma: varied histological presentations with a benign clinical course. An analysis of 55 cases.

Authors:  C Della Rocca; A G Huvos
Journal:  Am J Surg Pathol       Date:  1996-07       Impact factor: 6.394

8.  FYN promotes breast cancer progression through epithelial-mesenchymal transition.

Authors:  Ye-Gong Xie; Yue Yu; Li-Kun Hou; Xin Wang; Bin Zhang; Xu-Chen Cao
Journal:  Oncol Rep       Date:  2016-06-22       Impact factor: 3.906

9.  Fusion of the COL1A1 and USP6 genes in a benign bone tumor.

Authors:  Ioannis Panagopoulos; Fredrik Mertens; Richard Löfvenberg; Nils Mandahl
Journal:  Cancer Genet Cytogenet       Date:  2008-01-01

10.  Osteoblastoma: clinicopathologic study of 306 cases.

Authors:  D R Lucas; K K Unni; R A McLeod; M I O'Connor; F H Sim
Journal:  Hum Pathol       Date:  1994-02       Impact factor: 3.466

View more
  3 in total

1.  Fusion of the COL4A5 Gene With NR2F2-AS1 in a Hemangioma Carrying a t(X;15)(q22;q26) Chromosomal Translocation.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Ingvild Lobmaier; Kristin Andersen; Marius Lund-Iversen; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

2.  Integrated WGCNA and PPI Network to Screen Hub Genes Signatures for Infantile Hemangioma.

Authors:  Miao Xu; Tianxiang Ouyang; Kaiyang Lv; Xiaorong Ma
Journal:  Front Genet       Date:  2021-01-15       Impact factor: 4.599

3.  Methylation and copy number profiling: emerging tools to differentiate osteoblastoma from malignant mimics?

Authors:  Baptiste Ameline; Michaela Nathrath; Karolin H Nord; Felix Haglund de Flon; Judith V M G Bovée; Andreas H Krieg; Sylvia Höller; Jürgen Hench; Daniel Baumhoer
Journal:  Mod Pathol       Date:  2022-03-28       Impact factor: 8.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.